REFERENCES
- Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211–5.
- Vincent JL, Bihari D, Suter PM. The prevalence of nosocomial infection in intensive care units in Europe - the results of EPIC study. JAMA 1995; 274: 639–44.
- Vincent JL. Microbial resistance: lessons from EPIC study. Intensive Care Med 2000; 26: S3–S8.
- Mathay D, Lewis MT, Kugler KC, Pfaller MA, Jones RN. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I-results from the SENTRY antimicrobial surveil-lance program (North America 1998). Diagn Microbiol Infect Dis 2001; 39: 105–16.
- Flournoy DJ, Reinert RL, Bell-Dixon C, Gentry CA. Increasing antimicrobial resistance in gram-negative bacilli iso-lated from patients in intensive care units. Am J Infect Control 2000; 28: 244–50.
- Barsic B, Beus I, Marton E, et al. Antibiotic resistance among gram-negative nosocomial pathogens in the intensive care unit: Results of 6-year body-site monitoring. Clinical Therapeutics 1997; 19: 691–700.
- Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118: 146–55.
- Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999; 115: 462–74.
- Fridkin SK, Steward CD, Edwards JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospi-tals. Clin Infect Dis 1999; 29: 245–52.
- Barsic B, Marton E, Himbele J, Maretic T, Klinar I, Vranjican Z. Utilization of antibiotics in intensive care units. Neurologia Croatica 1997; 46 (Suppl 1): 13–20.
- Hanberger H, Garcia-Rodrigez J-A, Gobernado M, Goosens H, Nilsson L, Struelens MJ. Antibiotics susceptibility among aerobic Gram-negative bacilli in intensive care units in 5 European countries. JAMA 1999; 28: 67–71.
- Niederman MS. Impact of antibiotic resistance on clini-cal outcomes and the coast of care. Crit Care Med 2001; 29 (Suppl.4): 114-119.
- Leibovici L, Sharga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998; 244: 379–386
- Rello J, Saborges M, Correa H, Leal SR, Baraibar J. Variations in etiology of ventilator- associated pneumonai across four treatment sites: Implication for antimicrobial pre-scribing practices. Am J Respirat Crit Care Med 1999; 160: 608–13.
- Barsic B, Beus I, Marton E, Himbele J, Kuzmanovic N, Bejuk D. Bolnicke infekcije i rezistencija na neke novije antibiotike u jedinici intenzivne skrbi: Ovisnost o dijagnosticko-terapijskim zahvatima. Lij Vjesn 1991; 113: 401–4.
- Barsic B, Beus I, Marton E, et al. Antibiotic resistance among gram-negative nosocomial pathogens in the intensive care unit: Results of 6-year body-site monitoring. Clin Therapeut 1997; 19: 691–700.
- Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16: 128–40.
- Acourt CHD, Garrard CS, Crook D, et al. Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture. Quart J Med 1993; 86: 635–48.
- National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests. M2-A4.NCCLS, Villanova, PA, 1990.
- Spencer R, Bauernfeind A, Garcia-Rodriguez J, et al. A surveillance of the current resistance of nosocomial pathogens to antimicrobials. Clin Microbiol Infect 1997; 3 (Suppl. 1): S21-35.
- Sörberg M, Farra A, Ransjo U, et al. Long-term antibi-otic resistance surveillance of gram-negative pathogens sug-gests that temporal trends can be used as a resistance warning system. Scand J Infect Dis 2002; 34: 372–8.
- Stratton CW, Ratner H, Johnston PE, Schaffner W. Focused microbiologic surveillance by specific hospital unit as a sensitive means of defining antimicrobial resistance prob-lems. Diagn Microbiol Infect Dis 1992; 15 (Suppl): 11S- 18S.
- Morris AK, Masterton RG: Antibiotic resistance surveil-lance: action for international studies. J Antimicrob Chemother 2002; 49: 7–10.
- Hanberger H, Hoffmann M, Lindgren S, Nilsson LE. High incidence of antibiotic resistence among bacteria in 4 intensive care units at a university hospital in Sweden. Scand J Infect Dis 1997; 29: 607–14.
- Mahgoub S, Ahmed J, Glatt AE. Completely resistant Acinetobacter baumannii strains. Infect Control Hosp Epidemiol 2002; 23: 477–9.
- Nicoletti G, Bonfiglio G, Bartoloni A, et al. Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units: a 2-year comparison. Int J Antimicrob Agents 2000; 15: 265–9.
- Livermore DM, Yuan M. Antibiotic resistance and pro-duction of extended-spectrum beta-lactamases amongst Klebsiella spp. From intensive care units in Europe. J Antimicrob Chemother 1996; 38: 409–24.
- Asensio A, Oliver A, Gonzales-Diego P, et al. Outbreak of a multiresistant Klebsiella pneumoniae strain in an inten-sive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis 2000; 30: 55–60.
- Paterson DL, Mulazimoglu L, Casellas JM, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000; 30: 473–8.
- Tambic Andrasevic A, Tambic T, Kalenic S, Jankovic V. Surveillance for antibiotic resistance in Croatia. Emerg Infect Dis 2002; 8: 14–18.
- Fridkin SK, Hill HA, Volkova NV, Edwards JR, Lawton RM, Gayness RP, McGowan JE. Temporal changes in preva-lence of antimocrobial resistance in 23 U.S. hospitals. Emerg Infect Dis 2002; 8: 697–700.
- Lepper PM, Grusa E, Reichl H, Hogel J, Trautmann M. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2002; 46: 2920-5. Tambic A, Power EGM, Tambic T, Snur I, French GL. Epidemiological Analysis of methicillin-resistant Staphylo-coccus aureus in a Zagreb Trauma Hospital using a randomly amplified polymorphic DNA-typing method. Eur J Clin Microbiol Infect Dis 1999; 18: 335–40.